DACTOLISIB: 18 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
18
Total FAERS Reports
2 (11.1%)
Deaths Reported
12
Hospitalizations
18
As Primary/Secondary Suspect
First Report: 20120730 · Latest Report: 20131001
What Are the Most Common DACTOLISIB Side Effects?
#1 Most Reported
Diarrhoea
10 reports (55.6%)
#2 Most Reported
Nausea
9 reports (50.0%)
#3 Most Reported
Vomiting
8 reports (44.4%)
All DACTOLISIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 10 | 55.6% | 0 | 6 |
| Nausea | 9 | 50.0% | 0 | 5 |
| Vomiting | 8 | 44.4% | 0 | 5 |
| Headache | 7 | 38.9% | 0 | 5 |
| Hepatic pain | 6 | 33.3% | 0 | 5 |
| Lethargy | 6 | 33.3% | 0 | 5 |
| Malignant neoplasm progression | 6 | 33.3% | 0 | 5 |
| Pancreatic neuroendocrine tumour | 6 | 33.3% | 0 | 5 |
| Therapy non-responder | 6 | 33.3% | 0 | 5 |
Who Reports DACTOLISIB Side Effects? Age & Gender Data
Gender: 5.9% female, 94.1% male. Average age: 46.4 years. Most reports from: US. View detailed demographics →
Is DACTOLISIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 1 | 0 | 1 |
| 2013 | 9 | 2 | 8 |
What Is DACTOLISIB Used For?
| Indication | Reports |
|---|---|
| Pancreatic neuroendocrine tumour | 6 |
Official FDA Label for DACTOLISIB
Official prescribing information from the FDA-approved drug label.